Watson Health

Using Watson to Stay On Top of Cancer Care Data

Share this post:

In 2012, an estimated 14.1 million people were diagnosed with cancer worldwide, and my country, Slovakia, ranks 22nd in terms of overall cancer frequency. As the incidence of cancer continues to grow and time constraints on oncologists intensify, the need for research and treatment innovation is more important than ever.

The good news for patients is that more than 50,000 cancer clinical trials are published every year. And yet as new studies and evidence emerges – such as data being presented this week at the European Society for Medical Oncology in Madrid – it is nearly impossible for clinicians to stay on top of the latest cancer care data. This is why our hospital network is bringing AI into clinical practice to support doctors and patients.

In my position as Leading Physician of Cancer Center in Michalovce, Slovakia, I am one of 19 oncologists using IBM’s Watson for Oncology to help identify the most appropriate treatment options for each patient and sift through the growing amount of medical literature to better understand those options.

Like clinicians and researchers worldwide, the doctors here are working hard to provide the most effective treatments with the least toxicity to each of our patients, even as we battle significant time constraints and data overload. Watson for Oncology – which is trained by experts at Memorial Sloan Kettering Cancer Center in New York – serves as an important resource to help us identify the best approach.

In breast cancer, for example, there are nearly 70 drugs approved in the U.S.; determining which ones to use, and in which regimens, is an important decision. New treatments based on genomic and immunotherapy options are changing lives, and Watson for Oncology can help the clinician sort through these various therapeutic options.

Every year at these important global cancer congresses, we witness new results from clinical trials and we are advancing new standards of care in many different cancer types. As this proliferation of data and evidence makes cancer treatment decisions even more complicated than in previous years, having the help of artificial intelligence to make clinical decisions will be useful for oncologists in Slovakia and around the globe as well.

I think this is just the beginning for AI in healthcare. Currently I am helping the Svet Zdravia network to develop a “next generation” hospital and this new facility will include a variety of cancer treatment specialties, as well as technologies that help these sub-specialists access data-driven insights to support the care they provide to their patients, right in the context of their work flow. Watson for Oncology will be used in our Tumor Board meetings once the new facility is open, and I am delighted with having this new clinical tool at our disposal.

Svet Zdravia Hospital Network, Slovakia

More Watson Health stories

IBM Responds to California Fires

At the time of this writing, the death toll from California’s deadliest wildfires stands at 66 – with more than 600 people still unaccounted for. Meanwhile, the fires have destroyed more than 10,000 homes, forced more than 81,000 people to evacuate, and are less than 40 percent contained. It’s in times like these that IBM and […]

Continue reading

The Network Effect: IBM Blockchain Now Runs in Multiple Environments

Blockchain technology can mean many things to many people, but one key tenet of the technology is that it is dependent on the network effect. The larger, more open, diverse and distributed a network, the stronger its trust mechanisms and the greater its value to members across a network. However, this can create challenges in […]

Continue reading

Why I Serve

My name is Frank Johnson. I am a veteran, and an IBMer who works for veterans. If all I had was one sentence to communicate what I feel and do every day, that sentence is it. I spent eight years active duty in the United States Air Force, and two more in the Virginia National […]

Continue reading